SYSTEMS AND METHODS FOR CREATING CHANNELS IN AN EYE USING LASER PULSES FOR THE TREATMENT OF GLAUCOMA
20240268999 ยท 2024-08-15
Inventors
Cpc classification
A61F9/00781
HUMAN NECESSITIES
International classification
Abstract
Methods and devices for treating target tissue layers of an anterior chamber angle of an eye, using novel photo disruptive laser pulses delivered to multiple target tissue layers of the eye and thereby creating openings and channels in said tissue layers that create additional outflow channels for Aqueous humor out of the eye and thereby reducing the intraocular pressure of the eye and therefore treating Glaucoma.
Claims
1. A method for increasing aqueous humor outflow of an eye, having a cornea, an anterior chamber filled with aqueous humor, having natural outflow pathways, an anterior angle area which is including a Trabecular Meshwork, a scleral spur, a Schlemm's canal, a collector channel, scleral tissue and a transition region between a sclera and a choroid within and around the anterior angle area of the eye, the method comprising: delivering focused photo disruptive laser pulses through the cornea into the anterior chamber and towards a first target tissue layer within the anterior angle area such that a first opening through said first target tissue layer is created and further the focused photo disruptive laser pulses being scanned through said first opening onto a second target tissue layer within the anterior angle area such that a second opening or channel into the second target tissue layer is created and thereby creating an additional outflow pathway for the Aqueous humor of the anterior chamber and thereby reducing the intraocular pressure of the eye.
2. A method of claim 1 where the first target tissue layer is the Trabecular Meshwork and the second target tissue layer is the collector channel.
3. A method of claim 1 where the first target tissue layer is the Trabecular Meshwork and the second target tissue layer is the scleral tissue.
4. A method of claim 1 where the first target tissue layer is the scleral spur and the second target tissue layer is the scleral tissue.
5. A method of claim 1 where the first target tissue layer is the scleral spur and the second target tissue layer is the scleral tissue.
6. A method of claim 1 where the first target tissue layer is the scleral spur and the second target tissue layer is the transition region between a sclera and a choroid.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] Various features of illustrative embodiments of the inventions are described below with reference to the drawings. The illustrated embodiments are intended to illustrate, but not to limit, the inventions. The drawing contain the following figures:
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
DETAILED DESCRIPTION OF THE INVENTIONS AND CLAIMS
[0050] The following chapters describe 5 novel Methods for laser eye surgery as well as several novel laser systems to perform such procedures.
[0051] In all further described methods and systems, the laser treatment beam enters the eye through the cornea e.g. see
1) Optimizing Outflow by Identifying and Targeting Collector Channels in the Eye to Treat Glaucoma:
[0052] As shown in
[0053] The here invented method consists of: [0054] a) determining the location of the collector channels of the to be treated eye before or while the treatment is performed. [0055] b) Correlating the collector channel locations map from a) with one or multiple reference points in or around the eye (e.g. correlating the collector channel map with a clock hour reference where 12 o clock is on the superior point of the limbus). [0056] c) Using the reference calibration from step b) and selecting one or multiple trabecular meshwork target areas near or right above one or multiple collector channels. [0057] d) Aiming the treatment laser and creating the holes at the selected target areas and thereby optimizing and improving the outflow capacity of the created holes.
[0058] For point a) the determination of the collector channels is being done with one or multiple of the following methods: [0059] Using a preoperative OCT (optical coherence Tomography) diagnostic device to find and map the location of the collector channels of the to be treated eye and if used with sufficient resolution the size of the collector channels as well. This pre-op OCT diagnostic scan can be performed long (days, weeks, . . . ) before the procedure since the collector channels are not significantly changing within weeks. [0060] Using an OCT device that is integrated or is used in conjunction with the laser treatment system, such that it scans the eye for collector channels just prior (seconds to minutes) to the laser treatment being performed. This method is used to either find and select collector channel, near which a laser treatment is then performed or to identify and calibrate or recalibrate the location of a previously mapped collector channel (e.g. from the pre-op mapping above). [0061] For both of the above described OCT diagnostic procedures, the OCT system can be scanned through either a goniolens (with or without integration to the laser and laser delivery system) and then through the anterior chamber towards the diagnostic target area or via a OCT system that penetrates the outer tissue layers of the eye around the limbus (with or without integration to the laser system). [0062] Creating a momentary and sudden drop in IOP of the to be treated eye while watching the trabecular meshwork through a gonio lens view. A sudden drop in IOP will result in a blood reflex, were some blood will travel from the collector channels backwards through Schlemms canal and through the Trabecular Meshwork above and then enters the anterior chamber where it mixes with the Aqueous Humor. This blood reflex can be visibly seen and the first appearance locations on the Trabecular Meshwork are right above or near the entrances of the collector channels. These positions can then be mapped. There are several known methods available to create a sudden drop in IOP. [0063] Using a Ultrasound biomicroscopy (UBM) system to identify and locate the collector channels. [0064] Using a dye injected into the anterior chamber to visualize the outflow into the collector channels and by doing so mapping the location and size (outflow strength) of the collector channels. [0065] Other imaging systems that can visualize the collector channels in an eye.
[0066] An optional tissue coagulation procedure can be applied to reduce or eliminate bleeding. See 2.e).
2) Opening the Entrance Area of a Collector Channels in the Eye to Treat Glaucoma:
[0067] In some glaucoma eyes the collector channels themselves have occlusions and restrictions that hinder the outflow of the Aqueous humor. In particular the entrance area of the collector channel can be partially or fully occluded by either a collapsed Schlemm's canal, a deformed or collapsed collector channel wall around the entry section or by tissue membranes and other tissue growth or debris that blocks part or all of the collector channel entrance. In this case opening a hole through Schlemm's canal even if it is placed near a collector channel will not result in good outflow.
[0068] For these cases the laser pulses are used to not only open the Trabecular Meshwork above the collector channel, but to further drill/cut an open channel into the entry section of the collector channel, see
3) Creating Openings in the Back Wall of Schlemm's Canal in an Eye to Treat Glaucoma:
[0074] In this here disclosed method the laser pulses are used to create one or multiple channel openings
[0075] These openings will create various novel outflow channels that will lower the IOP of a eye and therefore treat glaucoma.
[0076] This method does not require to locate or target the collector channel openings, however there is a statistical chance to randomly create a channel near or at an collector channel, depending on how many channels are cut and how large they are.
[0077] To minimize or eliminate the chance of bleeding an optional coagulation procedure as described in 2 e) above can be added.
4) Creating Openings Behind the Scleral Spur and into the Scleral Tissue of an Eye to Treat Glaucoma:
[0078] In this here disclosed method the photo disruptive laser pulses are used to create one or multiple channel openings
[0079] Staying mostly above the transition line to the choroid 7934 will minimize or eliminate the chance of bleeding. Optionally a coagulation procedure as described in 2 e) above can be added.
5) Creating Openings Behind the Scleral Spur and into the Scleral Tissue of an Eye to Treat Glaucoma:
[0080] In this here disclosed method the laser pulses are used to create one or multiple channel openings
[0081] Cutting/drilling into Choroid tissue increases the risk of bleeding and therefore optionally a coagulation laser procedure as described in 2 e) above can be added.
[0082]
Laser System Devices:
[0087] The here disclosed Methods 1 to 5 can be performed with a femtosecond photodisruptive laser system similar to the once known in femto LASIK and femto-Cataract procedure systems. The femto-laser pulses have a wavelength between 800 nm and 1500 nm, a pulse duration of 200 fs to 2000 fs, a pulse energy of 2 uJ to 100 uJ, focused to a spot size of 2-10 um spot diameter FWHM and a laser repetition firing rate of 100 Hz to 50 kH.
[0088] However, since all here described holes, channels and treated tissue areas are mostly in the 10 ?m to 500 um diameter opening range, no sub 10 um precision in the cutting of the here disclosed openings is required and since furthermore a relatively large volume >10000 um{circumflex over ()}3 (cubic micrometer) of tissue is being removed in the here disclosed methods, a longer pulsed laser with a larger spot size and a higher pulse energy is better suited to be used for these channels as long as the laser pulse peak fluence is still sufficient to achieve photo disruptive optical breakdown in the tissue area where the laser pulses are focused. The preferred laser system for the here disclosed methods 1 to 5 is therefore a nanosecond ns pulsed laser system with a pulse duration of 0.5 ns to 50 ns, a pulse energy of 50 uJ to 5 mJ, a spot size of 10 ?m to 100 um and a repetition rate of single shot to 1000 Hz.
[0089] The laser parameters are optimized such that a photo disruption is still happening in the focus area of the nanosecond laser pulses (similar to the photo disruption of the femtosecond laser pulses, but with higher energy and bigger shockwaves and larger cavitation bubbles).
[0090] Not only will such a longer pulsed laser (ns-Laser) cut the tissue channels much faster compared to a femtosecond laser, but it will also reduce the cost, complexity and size of the laser system and delivery system dramatically and will therefore allow these glaucoma procedures to be available to a much larger worldwide patient population due to its significantly lower cost.
[0091] A laser system producing ns laser pulses with the specification above that is configured for photo disruptive mode in the laser focal region of the target region of an eye is hereby disclosed for use of cutting channels in an eye according to the methods 1 to 5 above.
[0092] In another embodiment, the ns laser system above is being configured in a lower pulse energy and/or larger spot size mode (compared to the photo disruptive mode above) such that the laser-tissue effect falls below the photo disruptive energy density threshold and turns into a thermal mode where the laser pulses are being absorbed by the target tissue and increase the temperature of that target tissue. These thermal mode laser pulses are used to perform the tissue coagulation as described in 2 e) and used in Method 1 to 5.
[0093] In another embodiment the here disclosed ns-laser system is being switched from Thermal mode to Photo disruptive Mode and optionally back again under the input control of an operator or with an automatic preprogrammed switching sequence, This will allow the target tissue to be coagulated before or after (or both) the channel cutting laser pulses are applied to reduce or eliminate bleeding in the eye.